Acquired pure red cell aplasia following recombinant erythropoietin (darbepoetin-alfa) therapy
نویسندگان
چکیده
منابع مشابه
Acquired pure red cell aplasia.
Correspondence MEDICALTJOSRNAL 559 Acquired Pure Red Cell Aplasia SIR,-May we make the following observation about your article on acquired pure red cell aplasia and its treatment with steroids (6 April, p. 3) ? A pure red cell aplasia that responded to riboflavine or prednisone has been described in African adults and in children with marasmus and kwashiorkor.' In marasmus and kwashiorkor an e...
متن کاملPure Red Cell Aplasia Following Interleukin-2 Therapy.
A 61-year-old woman with metastatic renal cell carcinoma underwent systemic treatment with high-dose interleukin-2 (IL-2). Anemia requiring transfusion of 1 unit of packed red blood cells (PRBCs) was required during the second week of IL-2 therapy. One month following completion of high-dose IL-2 treatment, she was hospitalized for severe, symptomatic anemia and received 5 units of PRBCs. She w...
متن کاملEpoetin alfa (Eprex): reports of pure red blood cell aplasia.
© 2002 Canadian Medical Association or its licensors Reason for posting: Health Canada has alerted health care professionals of a letter issued by Janssen-Ortho Inc. warning of serious postmarketing adverse events associated with the anemia drug epoetin alfa (Eprex). Seven cases of pure red cell aplasia (PRCA) have been reported in Canada after an estimated 80 000 patient-years of exposure to t...
متن کاملMyelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
Myelodysplastic syndrome (MDS) with erythroid aplasia is a very rare disorder that has not been clearly defined. We experienced a case of pure red cell aplasia (PRCA), which evolved to MDS with erythroid aplasia. A 59-year-old male with transfusion-dependent PRCA was referred to our hospital for an evaluation of newly developed thrombocytopenia. Two years ago, PRCA was diagnosed by the laborato...
متن کاملPure Red Cell Aplasia Induced by Antibodies against Human Recombinant Erythropoietin
Human recombinant erythropoietin (epoetin) is a very effective and safe biopharmaceutical. However, in 1998 the incidence of pure red cell aplasia (PRCA) induced by antierythropoietin (anti-EPO) antibodies in patients treated with epoetin started to increase. PRCA is a rare condition of non-regenerative anemia which can be associated with a variety of diseases and is in some cases of immunologi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Nephrology
سال: 2020
ISSN: 0971-4065
DOI: 10.4103/ijn.ijn_129_19